Home » Topics » Regulatory

Regulatory
RSS

New indication explored for established anticonvulsant

July 21, 1998

Celgene cleared to market Thalomid in U.S.

July 20, 1998

One-year trial shows efficacy of lamivudine for treatment for chronic hepatitis B

July 20, 1998

New peristaltic stimulant on the way to market in Japan

July 9, 1998

Roberts and RiboGene sign development and marketing agreement for Emitasol

July 8, 1998

Granocyte granted expanded marketing authorization

July 7, 1998

Scientifically tested hair loss treatment introduced in Canada

July 1, 1998

Broadened use of Taxotere in breast cancer cleared by FDA

June 25, 1998

FDA approves biotech product for RSV disease in children

June 22, 1998

SangStat receives U.S. patent covering multiple ciclosporin formulations

June 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...